China's National Medical Products Administration has adopted the world's first global standard for AI-driven brain-computer interface medical devices. The standard, effective September 1, 2027, aims to unify data quality and development processes for devices that use AI to process electroencephalogram data.
China's leadership in setting global standards for AI-driven brain-computer interfaces could influence the future development and regulation of this rapidly advancing technology worldwide, impacting research, product approval, and market access.
China is spearheading the standardization of brain-computer interface (BCI) technologies by chairing a subcommittee focused on global standards for brain-computer communication and interaction. This initiative aligns with China's national development priority for BCI applications.
In parallel, China's National Medical Products Administration (NMPA) has adopted the world's first global standard for AI-driven BCI medical devices. This new standard, effective September 1, 2027, sets requirements for the entire data lifecycle, including collection, processing, storage, and system access, along with standardized testing methods for electroencephalogram (EEG) data. The NMPA aims to resolve challenges arising from inconsistent dataset qualities and non-standardized development processes that affect AI algorithm evaluations.
This marks China's third national standard in the BCI field, following a terminology standard issued in September 2025. The move is supported by regional governments and comes as several relevant medical products are in clinical trials. The standard focuses on formalizing technical quality criteria for AI training and evaluation datasets in clinical interface technology.
Pick the topics you care about. Get only what matters, on your cadence.